Services of MTRC

Medical technologies face several market access challenges in Europe, including reimbursement, funding (post-reimbursement approval by payers), and health technology assessment. To overcome some of these challenges, Med Tech companies need to develop clinical and economic evidence to support the value claims about medical technologies. MTRC helps medical technology companies reduce uncertainty about evidence requirements of key European reimbursement, funding, and HTA authorities and develop a clear plan to address key gaps with clinical and economic evidence. A White Paper "Evidence Gap Analysis for Medical Technologies in Europe – a Practical Example" presents the methodological approach or MTRC and a practical example of evidence gap analysis.

MTRC announces the start of the new service – evidence gap analysis for medical technologies in Europe. The service helps to establish the sufficiency of existing evidence to obtain reimbursement and endorsement by HTA organizations in Europe and offers recommendations for the generation of missing evidence. MTRC offers a fact-based, unbiased approach to determining clinical and economic evidence requirements, based on the benchmarking to the prevision reimbursement decisions of reimbursement authorities and HTA organizations. Recommendations are also based on an in-depth understanding of the reimbursement pathways in individual markets. Learn more on the dedicated page for this service.

Market access eventually comes down to the hospital or individual payer level. Interactive digital tools are the essential instrument to present the value of medical technologies. MTRC launched a service of digital health economic models to present the clinical and economic value of medical technologies to hospital administrators and payers. MTRC combines an unparalleled knowledge of market access realities, drivers and barriers to the adoption of medical technologies, costing for healthcare services in 34 European countries, health economic technical expertise, and the capacity to develop nice-looking digital presentation tools at a moderate cost. See a live demo of the digital model on the website.

Market access is a rapidly changing field and the landscape varies from country to country. To provide an additional, easy-to-access source of high-level information about key themes in the market access landscape for medical technologies and in-vitro diagnostic tests, MTRC launched Knowledge Zone on the website. Currently, Knowledge Zone includes information about the payment model, funding (post-reimbursement approval by payers), and role of HTA for five key European countries: England, France, Germany, Italy, and Spain. In the coming weeks, the Zone will expand to other European countries.

Health technology assessment plays an important role in market access for medical technologies in England. National Institute for Health and Care Excellence (NICE) is the key HTA organization with several programs dedicated to the assessment of medical technologies. One of the key med tech-related programs at NICE is the Interventional Procedures Program. MTRC developed an analytical White Paper with a summary of clinical evidence requirements for Interventional Procedures Program at NICE.

Market access for medical technologies is a challenging field. It includes co-existing frameworks of reimbursement (coding, payment mechanism tariffs), funding (post-reimbursement approval by payers) and health technology assessment (HTA). MTRC developed an analytical White Paper with a summary of key market access considerations in the largest European countries (England, France, Germany, Italy and Spain), including an overview of stakeholders, payment mechanisms, innovative payment schemes, funding, and the role of HTA.

Market access is a challenging field. Multiple priorities have to be managed within a limited budget. We would like to share the anonymized outlines of the projects in the HEOR and market access fields commissioned to MTRC to inspire our clients. The next example is the rapid development of value messages to support positioning and marketing activities.

Market access is a challenging field. Multiple priorities have to be managed within a limited budget. We would like to share the anonymized outlines of the projects in the HEOR and market access fields commissioned to MTRC to inspire our clients. The next example is the adaptation of the global models to settings of European countries.

Market access is a challenging field. Multiple priorities have to be managed within a limited budget. We would like to share the anonymized outlines of the projects in the HEOR and market access fields commissioned to MTRC to inspire our clients. The first example is the evidence gap analysis and evidence generation strategy.

We are happy to announce the further expansion of our HEOR Department with Dr. Dharna Gupta, a dentist by training and a Health Economist by profession. Dharna holds a Master of Public Health degree in Health Policy, Economics & Finance from the Tata Institute of Social Sciences, Mumbai, India (2020). Dharna is a public health researcher with expertise in health systems and policy research, costing analysis, health economic modeling, economic evaluations, and value-based pricing in governmental settings. For the past three years, she was part of the HTA team at the Postgraduate Institute of Medical Education & Research, India, where she has worked on health economic models in the field of oncology, policy briefs and treatment guidelines at the state and national levels, and contributed to the educational modules on evidence-based medicine and health economics. If you are interested in learning about our capabilities in evidence synthesis, please, reach out to us to arrange a call to discuss your needs.

MTRC offers a new service of paid hourly consultations by the Director, Dr Oleg Borisenko. Normally, MTRC works on a project basis with a fixed budget. However, the format of the project does not fit all our clients. Sometimes, instead of a project, a one-two-hour consultation can be sufficient to guide the company in the right direction in relation to European market access, evidence generation and other related topics. MTRC now offers the possibility of hourly paid consultations with Oleg Borisenko, one of the most knowledgeable experts in European Med Tech market access. Read about typical situations for such support and conditions in this post.

We are happy to announce the further expansion of our HEOR Department with Sandeep Moola, an Evidence Synthesis Specialist. Sandeep holds a Master’s degree in Health Services Management with Honors Care from Griffith University, Brisbane, Australia (2006) and a Master’s degree in Philosophy (Clinical Science) in Evidence-Based Health Care from the University of Adelaide, Australia (2012), and he has a Ph.D. degree in Evidence-Based Health Care from the University of Adelaide, Australia (2017). Sandeep has extensive experience working for one of the world’s leading organizations on evidence-based medicine, Joanna's Briggs Institute in Australia.